Nephrotic syndrome secondary to varicella - zoster virus infection in 20 cases of analysis.doc

 PAGE \* MERGEFORMAT 4 Nephrotic syndrome secondary to varicella - zoster virus infection in 20 cases of analysis [Abstract] Objective To understand the children with idiopathic nephrotic syndrome secondary to varicella - zoster virus infection in children with clinical manifestations, treatment and prevention. Methods 20 patients with nephrotic syndrome were treated with ribavirin and interferon therapy. Disable immunosuppressive agents, as appropriate, reduce the hormone dosage. Combined application of effective antibiotics, bacterial infection. Intermittent low-dose infusion of blood or intravenous infusion of gamma globulin. Results After treatment for 19 cases recovered, 1 patient who died for the merger purulent meningitis, died of cerebral edema and cerebral hernia. Conclusion The clinical application of ribavirin and interferon treatment of children with primary nephrotic syndrome secondary to varicella - zoster virus infection in good results. [Keywords:] Nephrotic syndrome; varicella - zoster virus; herpes simplex virus / infection; Glucocorticoids / therapeutic use; children Receiving glucocorticoids (the hormone), and immunosuppressive therapy in children with nephrotic syndrome, secondary infection is a more prominent problem. Are treated in our hospital’s pediatric primary nephrotic syndrome secondary to varicella - zoster virus (Varicella  zoster virus, VIV) infection in 20 cases of children with clinical manifestations, treatment and prevention of analysis are reported below. A clinical data 1.1 General Information 2007  01 ~ 2008  10 in Shenyang City hospital for infectious diseases treated in children with nephrotic syndrome in 20 cases, including 15 males and 5 females; aged 3 to 12 years old, ≤ 5 years and 9 cases; duration from 1 month to 3 years; secondary to chickenpox, 18 cases of herpes zoster in 2 cases. A separate general hospital over the same period 20 cases of chickenpox in children with the control group. 1.2 Diagnost